TI
ANIP icon

Turner Investments’s ANI Pharmaceuticals ANIP Stock Holding History

Turner Investments’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-17,700
Closed -$998K – 409
2014
Q4 		$998K Sell
17,700
-91,110
-84% -$4.02M 0.12% 270
2014
Q3 		$3.08M Buy
108,810
+75,630
+228% +$2.27M 0.18% 163
2014
Q2 		$1.14M Sell
33,180
-2,130
-6% -$66.8K 0.05% 367
2014
Q1 		$1.11M Buy
+35,310
New +$937K 0.03% 448

Other funds holding ANIP

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

Turner Investments's ANIP Position: Q1 2015 in Review

Turner Investments sold out of ANI Pharmaceuticals (ANIP) in Q1 2015, closing a stake of 17,700 shares — an estimated $998K sold.

Turner Investments first reported a position in ANIP in Q1 2014 and held it in 4 quarters. The position peaked at $3.08M in Q3 2014. 126 funds tracked by Wall St. Rank hold ANIP as of Q1 2015.

  • Turner Investments reported no remaining ANI Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • Turner Investments sold 17,700 ANI Pharmaceuticals shares in Q1 2015, an estimated $998K.
  • Turner Investments first reported a position in ANI Pharmaceuticals in Q1 2014 and held it in 4 quarters.
  • Turner Investments's ANI Pharmaceuticals position peaked at $3.08M in Q3 2014.
  • 126 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2015.

Based on Turner Investments's 13F filing for Q1 2015, filed 12 May 2015.